Table 3.
Characteristics of the rural opioid initiative cohort by history of hepatitis C virus treatment, 2018–2020
| Self-reported ever having HCV | HCV Treatment | |||||
|---|---|---|---|---|---|---|
| Received Treatment | Never Received Treatment | |||||
| N | % | N | % | N | % | |
| TOTAL | 944 | 111 | 12% | 833 | 88% | |
| Age | ||||||
| Median (IQR) | 36 | (29, 43.5) | 42 | (34, 53) | 35 | (29, 42) |
| Sex | ||||||
| Female | 440 | 47% | 48 | 43% | 392 | 47% |
| Male | 503 | 53% | 63 | 57% | 440 | 53% |
| Transgender | 1 | 0% | 0 | 0% | 1 | 0% |
| Missing | 0 | 0% | 0 | 0% | 0 | 0% |
| Rural Opioid Initiative Site | ||||||
| Illinois | 54 | 6% | 13 | 12% | 41 | 5% |
| Kentucky | 135 | 14% | 3 | 3% | 132 | 16% |
| North Carolina | 124 | 13% | 19 | 17% | 105 | 13% |
| New England1 | 199 | 21% | 33 | 30% | 166 | 20% |
| Ohio | 127 | 13% | 8 | 7% | 119 | 14% |
| Oregon | 45 | 5% | 1 | 1% | 44 | 5% |
| West Virginia | 92 | 10% | 6 | 5% | 86 | 10% |
| Wisconsin | 168 | 18% | 28 | 25% | 140 | 17% |
| Substance use category, past 30 days | ||||||
| No opioid or stimulant use | 26 | 3% | 5 | 5% | 21 | 3% |
| Opioid without stimulant use | 94 | 10% | 17 | 15% | 77 | 9% |
| Stimulant without opioid use | 86 | 9% | 15 | 14% | 71 | 9% |
| Opioid and stimulant use | 738 | 78% | 74 | 67% | 664 | 80% |
1. Defined as Massachusetts, New Hampshire, and Vermont